Sorrento Therapeutics Inc Share Price Other OTC
Equities
US83587F1030
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
15/03 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
12/03 | News Highlights : Top Company News of the Day - Tuesday at 5 AM ET | DJ |
Sales 2021 | 52.9M 4.41B | Sales 2022 | 62.84M 5.24B | Capitalization | 411M 34.32B |
---|---|---|---|---|---|
Net income 2021 | -428M -35.7B | Net income 2022 | -573M -47.8B | EV / Sales 2021 | 29.1 x |
Net Debt 2021 | 111M 9.23B | Net Debt 2022 | 84.53M 7.05B | EV / Sales 2022 | 7.89 x |
P/E ratio 2021 |
-3.2
x | P/E ratio 2022 |
-0.65
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.77% |
Managers | Title | Age | Since |
---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 59 | 01/89/01 |
Shawn Sahebi
COO | Chief Operating Officer | - | - |
Mike A. Royal
CTO | Chief Tech/Sci/R&D Officer | 70 | 03/14/03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kim D. Janda
BRD | Director/Board Member | 67 | 01/12/01 |
David Lemus
BRD | Director/Board Member | 61 | 01/17/01 |
Jaisim Shah
BRD | Director/Board Member | 63 | 11/13/11 |
1st Jan change | Capi. | |
---|---|---|
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |